By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cellect Biotechnology 

23 Ha'Taas Street

Kfar Saba    44425  Israel
Phone: 972-9-9741444 Fax: n/a


Cellect Biotechnology Ltd. was founded in 2011 by Kasbian Nuriel Chirich, Dr. Shai Yarkoni and Dr. Nadir Ashkenazy with a vision of enabling regenerative medicine to become reality.




Founders: Kasbian Nuriel Chirich, Shai Yarkoni and Nadir Ashkenazy

Founder and CEO: Shai Yarkoni

CFO: Eyal Leibovitz

CDO: Yaron Pereg

Key Statistics

Ownership: Public

Web Site: Cellect
Symbol: APOP

Company News
Cellect (APOP) Announces $4.3 Million Raise In A Registered Direct Offering 9/7/2017 8:04:16 AM
Cellect (APOP) Shares Will Be Traded From Next Week Exclusively On NASDAQ 9/5/2017 9:37:05 AM
FDA Grants Orphan Drug Status To Cellect (APOP)'s ApoGraft For Acute GvHD And Chronic GvHD 9/5/2017 8:16:03 AM
Cellect (APOP) Provides Corporate Update And Reports Second Quarter 2017 Financial Results 8/21/2017 6:48:57 AM
Following The US, Cellect (APOP) Receives Russian Patent Covering Any Device And Method Using Cellect's Flagship Technology - The Apograft 6/14/2017 9:13:58 AM
Cellect (APOP) Is Moving To Trade Exclusively On The NASDAQ 6/9/2017 9:57:41 AM
Cellect (APOP) Provides Corporate Update And Reports First Quarter 2017 Financial Results 5/30/2017 8:18:23 AM
David Braun, Head Of Merck KGaA (MKGAF.PK) Device Business (MD&S), Joins Cellect (APOP)'s Advisory Board 5/23/2017 7:39:06 AM
Cellect (APOP) Gets Green Light From FDA For Apograft IND Submission In The U.S. 5/3/2017 10:25:15 AM